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clinicopathological indicators of tumourmalignancy, in non-advanced prostatic
cancer.
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Introduction
Prostate cancer is a biologically heterogeneous
disease.Manypatientswithlocalized,slow-growing
cancers survive fora longtimeeven in theabsence











The development of prostate cancer is a multi-
step process, advancing from high-grade prostatic
intraepithelial neoplasia (PIN) to focal carcinoma,
invasivecarcinoma,andfinallytometastaticdisease.
Therefore the planning of future therapies should






demonstrated that the expression of factors stim-
ulating angiogenesis, such as vascular endothelial






There are many parameters associated with the
process of angiogenesiswhichmay be evaluated in
tumours. One of such parameter is microvascular
density (MVD)[9].Thisparametercanbeassessed
based on the expression of CD34 or CD31 on the
endothelial cells of theblood vessels.On the other















giogenesis markers assessed in the tumour [14].


















One hundred and ten patients with early stage
prostatecancer,whohadbeendiagnosedusingTRUS/






American Joint Committee on Cancer (AJCC) and
the International Union Against Cancer. Grading
wasestablishedbasedontheGleasonscore(GS)dif-
ferentiationsystem(range2-10)[16],independently







The protocol was approved by the local bioethical
committeeandeverypatientsubmittedwrittenconsent.
Computed tomography examination
Computed tomography examinations were per-
formedwitha16-sectionmultidetectorCT(MDCT)
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arateof5ml/sviaan18-gaugecannula,whichwas
placedintherightantecubitalveininallthepatients
to exclude any source of variability. Computed to-
mographyperfusionscanningstarted5secondsafter
contrast administration,with the following param-
eters:4 contiguous5-mmreconstructed sectionsat
a constant table position, 1-second gantry rotation
time, 80 kVp and 180mA. Imageswere acquired
everysecondfor50seconds.









ferred to an image-processingworkstation (Advan-
tage Windows 4.2, GE Healthcare). Computed
tomography perfusion data was analyzed by two
radiologistsworking separately (EL and STD)with
4and3yearsofexperienceinCTPimagingrespective-
ly.Commerciallyavailablesoftware(CTPerfusion4,
GEHealthcare) was used for analysis, using a de-
convolution-basedtechnique.Thearterialinputwas
obtainedfromastandardizedplace intheregionof
theexternal iliacartery (EIA),withselectionof the
sectionthatallowedforbestvisualizationinorderto


















tissue separately.Fordisplaypurposes, the functional
mapswerepresentedincolouredimages(Fig.1).
Immunohistochemical assessment  
of parameters associated  
with tumour angiogenesis
Immunohistochemistry was performed on forma-



















Tumors 110 43.9±1.2 5.0±0.2 8.2±0.2 31.7±1.2 100.1±2.7 14.8±1.4
Normaltissue 110 25.2±0.9 2.4±0.1 6.5±0.1 19.6±0.9 – –
p-value1 0.00 0.00 0.00 0.00 – –
Degreeofhistologicalmalignancy
G1 65 42.0±1.5 4.7±0.2 8.1±0.2 30.2±1.7 99.9±3.6 16.2±2.0
G2 39 45.1±1.8 5.4±0.3 8.4±0.2 32.9±1.7 102.0±4.6 13.1±2.6
G3 6 56.7±8.7 5.0±0.6 8.4±0.2 40.1±6.0 90.4±3.8 15.8±4.6
p-value2 0.02 0.2 0.55 0.14 0.65 0.62
pTNM
1 8 51.9±7.2 4.5±0.4 8.0±0.5 34.9±5.5 99.7±7.1 10.7±1.9
2 66 42.4±1.5 4.9±0.2 8.1±0.2 29.2±35.7 97.6±3.0 14.4±2.1
3 31 44.9±2.1 5.4±0.3 8.4±0.2 35.7±2.2 107.0±6.3 17.0±2.7
4 5 44.2±5.7 4.9±0.6 8.0±0.3 35.0±5.1 90.0±17.8 19.1±6.8
p-value2 0.24 0.45 0.84 0.09 0.91 0.70
1probability of difference between mean value depend on T-test for dependent samples
2probability of difference between mean value depend on ANOVA test
BF – blood flow, BV – blood volume, MTT – mean transit time, PS – permeability-surface area product, MVD – microvessel density, VEGFLI – vascular endotheli-
al growth factor labelling index
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temperature 95-99°C, 20min., (ii) forCD34– pH
6, temperature 95-99°C, 40min. For quenching of
the activity of endogenous peroxidases, slides were
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Statistical analysis









perfusion parameters reveal the best diagnostic ac-




were performed using the STATISTICA 10.0 soft-
ware(StatSoft,Inc.,Tulsa,OK.USA).
Results
Perfusion computed tomography results
Themeanvaluesofperfusionparametersforpros-
tatecancerandnormaltissuearepresentedinTableI.
Significantly higher values of BF, BV, MTT and





low grade than in high grade carcinomas (Table I,
p<0.05).Similarly,themeanvaluesofPSwerelow-
erfortheG1tumoursthanforG3tumours,butthis


















ity, 52% specificity and 48% accuracy (Fig. 2). In
Table II. Thecorrelationbetweenmicrovesseldensity,VEGFexpressionandperfussionparametersinprostatecancer
bV (ml/100 g) mTT (s) ps (ml/min/100 g) mVd Vegrli






























r – coefficients of correlation; p – probability
BF – blood flow, BV – blood volume, MTT – mean transit time, PS – permeability-surface area product, MVD – microvessel density, VEGFLI – vascular endotheli-
al growth factor labelling index
Table III.TheresultsoftheROCcurveanalysis
bf (ml/min/100 g) bV (ml/100 mg) mTT (s) ps (ml/min/100 g)
Theareaunderthecurve
AUC±SE
0.60±0.06 0.62±0.05 0.58±0.06 0.57±0.06
p 0.05 0.01 0.09 0.12
Thresholdvalue 41.7 4.55 8.71 20.71
BF – blood flow, BV – blood volume, MTT – mean transit time, PS – permeability-surface area product, MVD – microvessel density
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The correlation between perfusion 
computed tomography results and tumour 

















In the case of prostate cancerMRI is a gold di-
agnostic standard. On the other hand computed
tomography (CT) was not considered as such, and
henceintheliteraturetherearefewreportsreferring
toapplicationofthismethodinprostatecancer.








cancer, benign prostatic hyperplasia (BPH) chron-




Similarly to the aforementioned results, but in
alargerpatients’group(110patients)weobserved:
significant differences betweenmean values of BV,
BF,MTTandPSinnormaltissueandprostatecan-




poorly differentiated tumours. This result suggests
that,alltheabove-mentionedCTPparametersmay
beofdiagnostic,prognosticandpredictivevalue.
A increase inBFvalues,describedbyus inneo-
plastic tissue compared to healthy areas, may be
explained by the opening of arterio-venous collat-
eral circulationwithin the tumour. These branches






be confirmed by the correlation between BV and
MVD,whichwasfoundinthepresentstudy.
Lastly, a higher PS value in the tumour than in








As described before, similarly to Osimani et al.
[15]wefoundasignificantcorrelationbetweenmi-
crovasculardensityandthreeparametersassessedin
CTP:BV,MTT andPS. This resultmight suggest






possible because differences in vascular permeability
andarchitecturebetweentumourandnormaltissues
(detectedwithCTP)maycontributetodifferencesin
oxygenation or gene expression and therefore influ-
Fig. 2. TheROCcurvesforPCperfusionparameters:BF
(greencolour);BV(redcolour);referenceline(blackcolour).
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gated vascular shoots, whose ends join together to
form capillary loops. The endothelial cells in new-
ly created vascular loops of tumour have abnormal
shapeandsize.Theyhavewideintercellularconnec-
tions,areirregularandhavealeakybasementmem-
brane. The above-mentioned hypothesis might be
confirmed by correlation betweenMTT andMVD
[30],whichwasnotedinourstudy.
HighBFvalues,whichweresignificantlyrelated





1.BasedonCTPparameters it ispossible to reveal
neoplasticfociwithintheprostate.Hencetheap-






itate pretreatment indication ofmore aggressive
carcinomasandhence,applicationofmoreagres-
sive treatment schedules/targeted therapies/anti-
vasculartherapy.
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